In summary, our work provides new insights into the posttranslational modification of COP1 and β-catenin in ovarian cancer and highlights that KAT6A functions as an acetyltransferase of nonhistone proteins, by which KAT6A is implicated in tumor progression. The gene discussed is COP1; the disease is ovarian carcinoma.